ONE-WAYDated event · through FY2025
KP-100IT Phase III and Additional Clinical Trials and Marketing Authorization Application
A regulatory and clinical development project for the individual product KP-100IT, a treatment for acute spinal cord injury. The project aims to complete the Phase III trial, obtain data through additional clinical trials, and submit an application for marketing authorization.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2020 →Last written FY2025
Directionhelps1 helps · 0 hurts · 0 flat